Novartis AG (NVS): One of the Best Low Risk High Growth Plays on the Market

We just covered the 14 Best Low Risk High Growth Stocks to Buy Right Now and Novartis AG (NYSE:NVS) ranks 7th on this list.

Following the successful spin-off of its Sandoz generics division in late 2023, Novartis AG (NYSE:NVS) has transformed into a high-margin, pure-play innovative medicines company that is currently outpacing its peers in both pipeline velocity and capital efficiency. In early 2026, Novartis reported that its core growth drivers, Kisqali (breast cancer), Kesimpta (multiple sclerosis), and Pluvicto (radioligand therapy), were seeing explosive growth. Specifically, Kisqali sales surged by 57% and Pluvicto by 42% in constant currencies, providing the high-growth kicker that elite investors look for. The firm has built a massive competitive moat in radioligand therapy. With the FDA-approved Millburn facility scaling up in early 2026, the company is effectively the leader of this high-margin cancer treatment niche.

READ ALSOD. E. Shaw Stock Portfolio: Top 10 Stocks to Buy.

Novartis AG (NYSE:NVS) stock offers utility-like safety combined with tech-like margins. The company achieved a 40.1% core operating margin in 2025/2026, an elite figure that provides a massive buffer against inflationary pressures and R&D costs. It generated $17.6 billion in free cash flow last year. This liquidity allows it to fund mid-sized bolt-on acquisitions, like the $2 billion Excellergy deal in March 2026, without stressing its balance sheet or taking on dangerous debt. Novartis is a premier income sanctuary. In early 2026, it proposed a dividend of CHF 3.70 per share, a 5.7% increase, yielding approximately 3%. It has a decades-long track record of uninterrupted payouts, providing a reliable paycheck for patient holders.

While we acknowledge the risk and potential of NVS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than NVS and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXTIsrael Englander Stock Portfolio: Top 10 Stock Picks and Billionaire Stan Druckenmiller’s 10 Small and Mid-Cap Stock Picks with Huge Upside Potential.

Disclosure: None. Follow Insider Monkey on Google News.